ParaZero Faces Steep Losses, Seeks Capital Amidst Early Commercialization

TL;DR

**PRZO is a high-risk bet on future drone safety tech, currently burning cash with no significant revenue and a clear need for more capital, so expect volatility and potential dilution.**

AI Summary

ParaZero Technologies Ltd. (PRZO) is an early commercialization stage company that has incurred significant losses since its inception and anticipates continued losses until its products are successfully commercialized. The company has not generated any significant revenue from current product sales and expects to require substantial additional capital to achieve profitability. Key risks include the inability to obtain necessary regulatory approvals from the Israeli Defense Export Control Agency, intense competition in evolving markets characterized by rapid technological change, and potential disruptions in its supply chain for critical components. The company's strategic outlook focuses on identifying and commercializing new products and services, but this involves substantial research and development and sales and marketing costs that could reduce profitability without guaranteed returns. As of December 31, 2025, ParaZero had 19,666,030 ordinary shares outstanding, increasing to 23,426,906 by March 25, 2026, indicating potential dilution. The company is an 'emerging growth company' and has elected to take advantage of extended transition periods for accounting standards.

Why It Matters

ParaZero's 20-F filing highlights the precarious position of an early-stage company in a rapidly evolving market like drone safety and counter-UAS. For investors, the lack of significant revenue and anticipated need for substantial additional capital signals high risk and potential for significant dilution, as evidenced by the increase in outstanding shares from 19,666,030 to 23,426,906 in just three months. Employees face uncertainty regarding the company's long-term financial stability, while customers might benefit from innovative safety solutions if the company can overcome its commercialization hurdles. The broader market for drone technology and safety is highly competitive, with ParaZero needing to make significant technological advances to differentiate itself against established players and new entrants.

Risk Assessment

Risk Level: high — The risk level is high due to ParaZero's status as an 'early commercialization stage company' with 'limited operating history' and having 'incurred significant losses since the date of our inception.' The filing explicitly states, 'We have not generated any significant revenue from the sale of our current products and may never be profitable,' and 'We expect that we will need to raise substantial additional capital before we can expect to become profitable.' This indicates severe financial instability and a high probability of further dilution.

Analyst Insight

Investors should approach PRZO with extreme caution, recognizing it as a highly speculative investment. Monitor closely for any significant revenue generation or successful capital raises, as the company's current trajectory suggests a high risk of failure or substantial dilution without these milestones.

Financial Highlights

debt To Equity

Not Disclosed

revenue

Not Disclosed

operating Margin

Not Disclosed

total Assets

Not Disclosed

total Debt

Not Disclosed

net Income

Not Disclosed

eps

Not Disclosed

gross Margin

Not Disclosed

cash Position

Not Disclosed

revenue Growth

Not Disclosed

Key Numbers

• 19,666,030 — Ordinary Shares Outstanding (As of December 31, 2025, indicating current share count)
• 23,426,906 — Ordinary Shares Outstanding (As of March 25, 2026, showing a significant increase in shares outstanding over a short period, suggesting dilution)
• NIS 0.02 — Par Value per Ordinary Share (The nominal value of each ordinary share)
• 12 months — Cash Runway Expectation (The company believes existing cash will fund operations for more than one year from financial statement issuance, but this is a forward-looking statement)

Key Players & Entities

• ParaZero Technologies Ltd. (company) — Registrant of the 20-F filing
• PRZO (company) — Trading symbol on The Nasdaq Stock Market LLC
• Ariel Alon (person) — Chief Executive Officer of ParaZero Technologies Ltd.
• Israeli Defense Export Control Agency (regulator) — Governmental agency whose approvals are necessary for sales expansion
• The Nasdaq Stock Market LLC (regulator) — Exchange where Ordinary Shares are registered
• $1.235 billion (dollar_amount) — Threshold for annual gross revenues to cease being an 'emerging growth company'
• $700 million (dollar_amount) — Threshold for aggregate worldwide market value to become a 'large accelerated filer'
• $1.0 billion (dollar_amount) — Threshold for non-convertible debt securities issued over three years to cease being an 'emerging growth company'
• U.S. Jumpstart Our Business Startups Act of 2012 (regulator) — Legislation defining 'emerging growth company'
• Sarbanes-Oxley Act of 2002 (regulator) — Legislation with auditor attestation requirements

Forward-Looking Statements

• ParaZero Technologies Ltd. will likely provide detailed financial statements for the fiscal year 2025 within the 'ea0282637-20f_parazero.htm' document. (ParaZero Technologies Ltd.) — high confidence, target: 2026-03-26
• The company's performance metrics for 2025, including revenue and net income, will be a key focus for investors reviewing this 20-F. (ParaZero Technologies Ltd.) — high confidence, target: 2026-03-26

FAQ

Risk Factors

• Israeli Defense Export Control Agency Approval [high — regulatory]: Failure to obtain necessary regulatory approvals from the Israeli Defense Export Control Agency (DECA) is a significant risk. This approval is critical for the company's ability to export its drone safety systems, directly impacting revenue generation and market access.
• Intense Competition and Rapid Technological Change [high — market]: The drone industry is characterized by rapid technological advancements and intense competition. ParaZero faces risks from new entrants and established players, potentially eroding market share and profitability if it cannot keep pace with innovation.
• Supply Chain Disruptions [medium — operational]: The company relies on a supply chain for critical components. Disruptions, such as shortages or quality issues, could significantly impact production schedules, increase costs, and delay product delivery, affecting financial performance.
• Need for Substantial Additional Capital [high — financial]: ParaZero has incurred significant losses and anticipates continued losses. The company expects to require substantial additional capital to achieve profitability, posing a risk of dilution and potential inability to secure necessary funding.
• Research and Development Costs [medium — financial]: The strategic focus on new product commercialization involves substantial R&D and sales/marketing costs. These expenditures may not yield guaranteed returns, potentially reducing profitability without a corresponding increase in revenue.

Industry Context

ParaZero operates in the drone technology sector, a rapidly evolving market characterized by intense competition and significant technological advancements. Key areas of focus include safety systems, autonomous flight, and specialized applications. The industry is seeing growth driven by commercial and defense applications, but also faces regulatory scrutiny and the need for robust safety certifications.

Regulatory Implications

ParaZero's operations are subject to stringent regulatory oversight, particularly from the Israeli Defense Export Control Agency (DECA). Obtaining and maintaining export licenses is critical for market access and revenue generation. Failure to comply with these regulations poses a significant risk to the company's business model.

What Investors Should Do

1. Monitor regulatory approval status from DECA.
2. Assess the company's ability to secure future funding.
3. Track competitive landscape and technological innovation.
4. Evaluate the progress of product commercialization.

Key Dates

• 2025-12-31: Ordinary Shares Outstanding — Indicates the share count at the end of the fiscal year.
• 2026-03-25: Ordinary Shares Outstanding — Shows a significant increase in shares outstanding over a short period, suggesting potential dilution.

Glossary

20-F

An annual report required by the U.S. Securities and Exchange Commission (SEC) for foreign private issuers that provides a comprehensive overview of the company's business and financial condition. (This document contains the detailed financial and operational information for ParaZero Technologies Ltd.)

Emerging Growth Company

A company that has total annual gross revenues of less than $1.235 billion during its most recently completed fiscal year. (ParaZero qualifies as an EGC and can take advantage of certain regulatory and accounting flexibilities.)

Ordinary Shares

The most common type of stock issued by a company, representing ownership and typically carrying voting rights. (The number of outstanding ordinary shares is a key metric for understanding ownership and potential dilution.)

Par Value

The nominal or face value of a share of stock, as stated in the corporate charter. (Indicates the minimum legal capital for the company and is a very low figure for ParaZero (NIS 0.02).)

Dilution

The reduction in the ownership percentage of a shareholder when a company issues new shares. (The increase in shares outstanding from December 31, 2025, to March 25, 2026, indicates potential dilution for existing shareholders.)

Year-Over-Year Comparison

Information comparing key metrics to the previous year is not available in the provided text. However, the increase in ordinary shares outstanding from 19,666,030 as of December 31, 2025, to 23,426,906 by March 25, 2026, indicates a significant dilution event or capital raise shortly after the fiscal year-end. No new specific risks were detailed in the provided excerpt, but the existing risks related to regulatory approvals, competition, and funding remain paramount.

Key Financial Figures

• $ — t, "NIS" means New Israeli Shekel, and "$," "US
  quot; and "U.S. dollars" mean United
• $1.235 billion — which our annual gross revenues exceed $1.235 billion; (ii) the last day of the fiscal year f
• $700 million — nts, held by non-affiliates is at least $700 million as of the last business day of our most
• $1.0 billion — date on which we have issued more than $1.0 billion in non-convertible debt securities duri
• $5,412,163 — eption in 2013, including net losses of $5,412,163 and $11,054,230 for the years ended Dec
• $11,054,230 — including net losses of $5,412,163 and $11,054,230 for the years ended December 31, 2025 a
• $34,889,450 — a result, we had accumulated losses of $34,889,450 as of December 31, 2025. We have devot

Filing Documents

• ea0282637-20f_parazero.htm (20-F) — 1715KB
• ea028263701ex12-1.htm (EX-12.1) — 9KB
• ea028263701ex12-2.htm (EX-12.2) — 9KB
• ea028263701ex13-1.htm (EX-13.1) — 3KB
• ea028263701ex13-2.htm (EX-13.2) — 3KB
• ea028263701ex15-1.htm (EX-15.1) — 2KB
• ea028263701_img1.jpg (GRAPHIC) — 3KB
• ea028263701_img2.jpg (GRAPHIC) — 4KB
• ea028263701_img3.jpg (GRAPHIC) — 3KB
• ea028263701_img4.jpg (GRAPHIC) — 15KB
• ea028263701_img5.jpg (GRAPHIC) — 15KB
• 0001213900-26-034376.txt ( ) — 7604KB
• przo-20251231.xsd (EX-101.SCH) — 60KB
• przo-20251231_cal.xml (EX-101.CAL) — 41KB
• przo-20251231_def.xml (EX-101.DEF) — 321KB
• przo-20251231_lab.xml (EX-101.LAB) — 573KB
• przo-20251231_pre.xml (EX-101.PRE) — 335KB
• ea0282637-20f_parazero_htm.xml (XML) — 777KB

Risk Factors

Risk Factors 1 ITEM 4. INFORMATION ON THE COMPANY 37 A. History and Development of the Company 37 B. Business Overview 37 C. Organizational Structure 56 D. Property, Plants and Equipment 56 ITEM 4A. UNRESOLVED STAFF COMMENTS 56 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 56 A. Operating Results 58 B. Liquidity and Capital Resources 61 C. Research and Development, Patents and Licenses 63 D. Trend Information 63 E. Critical Accounting Estimates 64 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 64 A. Directors and Senior Management 64 B. Compensation 68 C. Board Practices 70 D. Employees 81 E. Share Ownership 81 F. Disclosure of Registrant's Action to Recover Erroneously Awarded Compensation 83 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 83 A. Major Shareholders 83 B. Related Party Transactions 85 C. Interests of Experts and Counsel 86 ITEM 8. FINANCIAL INFORMATION 86 A. Consolidated Statements and Other Financial Information 86 B. Significant Changes 86 ITEM 9. THE OFFER AND LISTING 87 A. Offer and Listing Details 87 B. Plan of Distribution 87 C. Markets 87 D. Selling Shareholders 87 E.

Dilution

Dilution 87 F. Expenses of the Issue 87 i ITEM 10. ADDITIONAL INFORMATION 87 A. Share Capital 87 B. Articles of Association 87 C. Material Contracts 87 D. Exchange Controls 87 E. Taxation 87 F. Dividends and Paying Agents 97 G. 97 H. Documents on Display 97 I. Subsidiary Information 97 J. Annual Report to Security Holders 97 ITEM 11.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 97 ITEM 12.

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 99 PART II 100 ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 100 ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 100 ITEM 15.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 100 ITEM 16. [RESERVED] 101 ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 101 ITEM 16B. CODE OF ETHICS 101 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 101 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 102 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 102 ITEM 16F. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT 102 ITEM 16G. CORPORATE GOVERNANCE 102 ITEM 16H. MINE SAFETY DISCLOSURE 104 ITEM 16I DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 104 ITEM 16J INSIDER TRADING POLICIES 104 ITEM 16K CYBERSECURITY 104 PART III 105 ITEM 17.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 105 ITEM 18.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 105 ITEM 19. EXHIBITS 105

SIGNATURES

SIGNATURES 107 ii INTRODUCTION Unless the context otherwise requires, references in this annual report on Form 20-F, or this Annual Report, to the "Company," "Parazero," "we," "us," "our" and other similar designations refer to Parazero Technologies Ltd. All references to "ordinary shares" are to our ordinary shares, par value NIS 0.02. The financial statements were prepared in accordance with generally accepted accounting principles in the United States, or GAAP. Unless otherwise indicated, or the context otherwise requires, references in this Annual Report to financial and operational data for a particular year refer to the fiscal year of our Company ended December 31 of that year. Our reporting currency and functional currency is the U.S. dollar. In this Annual Report, "NIS" means New Israeli Shekel, and "$," "US

Forward-looking statements are not guarantees

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Important factors that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the factors summarized below: our limited operating history; our current and future capital requirements and our belief that our existing cash will be sufficient to fund our operations for more than one year from the date that the financial statements are issued; our ability to obtain necessary regulatory approvals from governmental agencies, or limitations put on the use of small unmanned aerial systems ("UASs") in response to public privacy concerns; our ability to manufacture, market and sell our products and to generate revenues; our ability to maintain our relationships with key partners and grow relationships with new partners; our ability to maintain or protect the validity of our U.S. and other patents and other intellectual property; our ability to launch and penetrate markets in new locations and new market segments; our ability to retain key executive members and hire additional personnel; our ability to maintain and expand intellectual property rights; interpretations of current laws and the passages of future laws; iv our ability to achieve greater regulatory compliance needed in existing and new markets; the overall demand for drone safety systems and counter unmanned aerial systems ("C-UAS"); our ability to achieve

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS Not applicable.

OFFER STATISTICS AND EXPECTED TIMETABLE

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE Not applicable.

KEY INFORMATION

ITEM 3. KEY INFORMATION A. [Reserved] B. Capitalization and Indebtedness Not applicable. C. Reasons for the Offer and Use of Proceeds Not applicable. D. Risk Factors You should carefully consider the risks described below, together with all of the other information in this Annual Report on Form 20-F. The risks and uncertainties described below are those material risk factors, currently known and specific to us, that we believe are relevant to an investment in our securities. Additional risks and uncertainties not currently known to us or that we now deem immaterial may also harm us. If any of these risks materialize our business, results of operations or financial condition could suffer, and the price of our ordinary shares could decline substantially. Summary Risk Factors Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled "Risk Factors" below. These risks include, among others, the following: Risks Related to Our Financial Condition and Capital Requirements We are an early commercialization stage company and have a limited operating history on which to assess the prospects for our business, have incurred significant losses since the date of our inception, and anticipate that we will continue to incur significant losses until we are able to successfully commercialize our products. We have not generated any significant revenue from the sale of our current products and may never be profitable. We expect that we will need to raise substantial additional capital before we can expect to become profitable from sales of our products. This additional capital may not be available on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate our product development efforts or other operations. 1 Risks Related to Our Business and Industry The Company expects to incur substantial research and development and sales and marketing

View Full Filing

View this 20-F filing on SEC EDGAR